Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial
Background and aim: Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by the obstruction of the main pulmonary artery due to thrombosis and vascular remodeling. Regarding the need for anticoagulant therapy in CTEPH patients, this study aimed to compare rivaroxaban with warfarin in term...
Main Authors: | Saghar Barati, Hossein Amini, Zargham Hossein Ahmadi, Alireza Dastan, Babak Sharif Kashani, Raha Eskandari, Farzaneh Dastan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Revista Portuguesa de Cardiologia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0870255122004589 |
Similar Items
-
Prevalence and predictors of chronic thromboembolic pulmonary hypertension following severe forms of acute pulmonary embolism
by: Joana Pargana, et al.
Published: (2023-12-01) -
Reoperação de tromboendarterectomia pulmonar em recidiva de tromboembolismo pulmonar crônico hipertensivo Repeat pulmonary thromboendarterectomy after recurrence of chronic thromboembolic pulmonary hypertension
by: Walter José Gomes, et al.
Published: (2009-01-01) -
Pulmonary thromboendarterectomy in Portugal: Initial experience
by: José Fragata, et al.
Published: (2020-09-01) -
Hand and wrist surgery without suspending warfarin or oral antiplatelet - systematic review
by: Trajano Sardenberg, et al. -
Cost-Effectiveness of Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism in Adult Patients Undergoing Elective Hip or Knee Replacement Surgery in Portugal
by: José Roxo Neves, et al.
Published: (2014-01-01)